| Therapeutic compositions, combinations, and methods of use |
2023-8-09 |
2023-8-31 |
|
| Combination therapy for treating abnormal cell growth |
2023-5-31 |
2023-12-07 |
|
| Solid forms of a dual raf/mek inhibitor |
2023-5-31 |
2023-12-14 |
|
| Compositions and methods for treating abnormal cell growth |
2023-3-01 |
2023-5-12 |
|
| Combination therapy for treating abnormal cell growth |
2023-1-24 |
2023-10-05 |
|
| Combination therapy for treating abnormal cell growth |
2022-12-09 |
2023-6-15 |
|
| Methods and compositions for treating abnormal cell growth |
2022-11-17 |
2023-10-12 |
|
| Methods of treating abnormal cell growth |
2022-11-02 |
2023-5-11 |
|
| Combination therapy for treating abnormal cell growth |
2022-10-27 |
2023-5-04 |
|
| Combination therapy for treating abnormal cell growth |
2022-7-27 |
2023-2-02 |
|
| Combination therapy to treat abnormal cell growth |
2022-2-04 |
2024-2-07 |
|
| Combination therapy to treat abnormal cell growth |
2022-2-04 |
2023-10-11 |
|
| Combination therapy for the treatment of abnormal cell growth |
2021-7-13 |
2023-5-02 |
|
| Methods of treating abnormal cell growth |
2021-4-27 |
2023-3-08 |
|
| Methods of treating cytokine release syndrome using a pi3k inhibitor |
2021-4-06 |
2021-10-14 |
|
| COMBINATION THERAPY FOR TREATMENT OF ABNORMAL CELL GROWTH |
2021-1-28 |
2022-10-11 |
|
| Methods of making cellular therapies |
2020-11-04 |
2022-12-08 |
|
| Treatment of cancers using pi3 kinase isoform modulators |
2020-7-24 |
2022-1-27 |
|
| Combination therapies |
2019-10-01 |
2021-11-04 |
|
| Pyrimidine substituted purine compounds as kinase (s) inhibitors |
2016-4-28 |
2016-12-16 |
|
| Oral dosing regimen of a dual mtor and pi3 inhibitor |
2015-12-28 |
2016-7-07 |
|
| Oral formulation of kinase inhibitors |
2015-11-27 |
2015-12-17 |
|
| Pyrimidine substituted purine derivatives |
2015-4-21 |
2015-10-30 |
|
| Sulfonyl amide derivatives for the treatment of abnormal cell growth |
2014-11-24 |
2015-3-19 |
|
| Pyrimidine substituted purine compounds as kinase inhibitors |
2014-1-21 |
2015-7-08 |
2015-7-08 |
| Pyrimidine substituted purine derivatives |
2013-10-31 |
2015-10-08 |
2015-10-08 |
| Oral formulations of kinase inhibitors |
2013-8-14 |
2016-6-28 |
2016-6-28 |
| Synthesis and use of kinase inhibitors |
2013-8-07 |
2016-11-29 |
2016-11-29 |
| Biomarkers for cancer stem cells and related methods of use |
2013-3-08 |
2015-1-29 |
|
| Methods of identifying gene isoforms for anti-cancer treatments |
2013-3-08 |
2013-9-12 |
|
| Therapeutic compounds and related methods of use |
2013-1-07 |
2013-7-11 |
|
| Therapeutic compositions and related methods of use |
2012-12-05 |
2013-6-13 |
|
| Pyrimidine replacing purine compound as kinase inhibitor |
2009-4-03 |
2015-11-11 |
|
| Pyrimidine derivatives for the treatment of abnormal cell growth |
2006-11-20 |
2014-5-13 |
2014-5-13 |
| 異常な細胞成長を処置するための併用療法 |
2022-2-04 |
2024-2-07 |
|